U.S. ex rel. Osheroff v. HealthSpring, Inc.

We represented HealthSpring, a publicly traded managed care organization, in DOJ/HHS-OIG investigation involving allegations that the defendant had violated the Anti-Kickback Statute and rules governing the marketing of Medicare Managed Care Organizations, resulting in declination of intervention by the government and district court’s dismissal of relator’s FCA claims.  See U.S. ex rel. Osheroff v. Healthspring, 938 F. Supp. 2d (M.D. Tenn. 2013).

HealthSpring, Inc. (NYSE: HS) is one of the largest Medicare Advantage coordinated care plans in the U.S.

You Also May Be Interested In:

  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee

    We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company
  • Bass, Berry & Sims served as lead counsel to Tennessee Orthopedic Alliance (TOA) in obtaining a Certificate of Need (CON)...
    Client Type: Private Company